US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Sunshine Biopharma Inc.

News headline image
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
From Sunshine Biopharma Inc.
Via ACCESS Newswire
Tickers SBFM
News headline image
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
From Sunshine Biopharma Inc.
Via ACCESS Newswire
Tickers SBFM
News headline image
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
From Sunshine Biopharma Inc.
Via ACCESS Newswire
Tickers SBFM
News headline image
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
From Sunshine Biopharma Inc.
Via ACCESS Newswire
Tickers SBFM
News headline image
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
From Sunshine Biopharma Inc.
Via ACCESS Newswire
Tickers SBFM
News headline image
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
From Sunshine Biopharma Inc.
Via ACCESS Newswire
Tickers SBFM
News headline image
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
From Sunshine Biopharma Inc.
Via ACCESS Newswire
Tickers SBFM
News headline image
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
From Sunshine Biopharma Inc.
Via ACCESS Newswire
Tickers SBFM
News headline image
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
From Sunshine Biopharma Inc.
Via ACCESS Newswire
Tickers SBFM
News headline image
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)
From Sunshine Biopharma Inc.
Via ACCESS Newswire
Tickers SBFM